Antabio is a Labège, France-based biopharmaceutical company dedicated to the discovery of first-in-class small molecule compounds to treat severe infections caused by antibiotic-resistant bacterial pathogens. The company has a particular focus on life-threatening respiratory infections, including carbapenem-resistant nosocomial pneumonia and chronic pulmonary diseases. Antabio’s lead program, MEM-ANT3310, is being developed for the treatment of hospital-acquired infections such as nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-resistant Enterobacterales (CRE).
Antabio is seeking a Regulatory Manager, reporting to the Head of Program Management, to support the Antabio team in all their regulatory activities. The qualified individual will have a scientific background, and previous experience in regulatory affairs. The candidate must have excellent communication and management skills and be able to interact with a multidisciplinary team across different time zones.